FDA issued a Warning Letter to Sato Yakuhin Kogyo Co., Ltd. on 1/6/2017 as a result of this inspection.
483 Sato Yakuhin Kogyo Jun 2016

483 Sato Yakuhin Kogyo Jun 2016

Justin Boyd FDA$119.00 - Available Now

FDA investigators audited the Sato Yakuhin Kogyo - Kashihara, Japan facility and issued inspectional observations (via FDA 483) on 10 Jun 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 10 Jun 2016
  • Location: Kashihara, Japan
  • FEI: 3003183265
Add To Cart